Definition and the target group of the studied PHC indicators
| Indicator | Target group | Definition |
| Influenza immunisation | Patients over 65 years | Proportion of PHC patients, age 65 years and older, who received an influenza immunisation in the previous 12 months |
| Mammography screening | 45–65 years-old female PHC patients | Proportion of female PHC patients, age 45–65 years, who received mammography in the previous 24 months |
| Serum creatinine measurement | Patients who redeemed antihypertensive drug at least four times in the previous 12 months (considered as patients with hypertension) | Proportion of PHC patients with hypertension screened for serum creatinine in the previous 12 months |
| Lipid measurement | Patients who redeemed antihypertensive drug at least four times in the previous 12 months (considered as patients with hypertension) | Proportion of PHC patients with hypertension and/or diabetes screened for lipid abnormalities in the previous 12 months |
| Beta-blocker application | Patients with AMI or CABG or PTCA | Proportion of patients with AMI, CABG or PTCA who used beta-blockers in the previous 12 months |
| HbA1c measurement | ATC A10 drug users | Proportion of PHC patients with diabetes mellitus screened for HbA1c in the previous 12 months |
| Eye examination | ATC A10 drug users | Proportion of PHC patients with diabetes mellitus who attended eye examination in the previous 12 months |
| Management of COPD | ATC R03 drug users and patients with COPD | Proportion of PHC patients with COPD who attended pulmonary function testing in the previous 12 months |
| Composite indicator | Total number of patients of each studied indicator | Proportion of PHC patients provided with recommended care; a general indicator of performance of GMP by summarising the number of care events and size of target populations of each studied indicator |
AMI, acute myocardial infarction; CABG, coronary artery bypass grafting; COPD, chronic obstructive pulmonary disease; GMP, general medical practice; HbA1c, haemoglobin A1c; PHC, primary healthcare; PTCA, percutaneous transluminal coronary angioplasty.